BLACK DIAMOND THERAPEUTICS INC. - COMMON STOCK

Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF, and FGFR Programs at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

08 أكتوبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

30 سبتمبر 2021 15:35:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

21 سبتمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

21 سبتمبر 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

12 أغسطس 2021 07:22:20 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors

10 أغسطس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

04 أغسطس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations

19 مايو 2021 16:00:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial

17 مايو 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

07 مايو 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical Oncology

28 أبريل 2021 09:38:27 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

10 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

25 مارس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

10 مارس 2021 15:58:50 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Pre-Clinical Data Presentations on New Programs Targeting BRAF and FGFR at ESMO TAT Virtual Congress 2021

02 مارس 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

23 فبراير 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series

11 فبراير 2021 15:15:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of Directors

20 يناير 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Conference

05 يناير 2021 06:45:00 بحسب Nasdaq GlobeNewswire